Adamsbrown Wealth Consultants LLC Acquires Shares of 401 UnitedHealth Group Incorporated (NYSE:UNH)

Adamsbrown Wealth Consultants LLC bought a new position in UnitedHealth Group Incorporated (NYSE:UNH) in the first quarter, Holdings Channel reports. The firm bought 401 shares of the healthcare conglomerate’s stock, valued at approximately $210,000.

Several other large investors have also recently modified their holdings of the business. NewSquare Capital LLC purchased a new position in UnitedHealth Group in the fourth quarter worth $25,000. Marshall & Sterling Wealth Advisors Inc. purchased a new stake in shares of UnitedHealth Group during the fourth quarter worth about $26,000. Hurley Capital LLC purchased a new stake in UnitedHealth Group in the fourth quarter worth $28,000. Aster Capital Management DIFC Ltd purchased a new stake in UnitedHealth Group in the fourth quarter worth about $30,000. Finally, Promus Capital LLC purchased a new position in UnitedHealth Group during the fourth quarter valued at $32,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Insider Transactions at UnitedHealth Group

In related news, Director Kristen Gil bought 3,700 shares of the stock in a transaction dated Thursday, May 15th. The shares were acquired at an average cost of $271.17 per share, for a total transaction of $1,003,329.00. Following the acquisition, the director now directly owns 3,818 shares in the company, valued at approximately $1,035,327.06. This trade represents a 3,135.59% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director John H. Noseworthy bought 300 shares of the business’s stock in a transaction on Wednesday, May 14th. The stock was bought at an average cost of $312.16 per share, with a total value of $93,648.00. Following the completion of the purchase, the director now directly owns 6,063 shares in the company, valued at approximately $1,892,626.08. The trade was a 5.21% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders acquired a total of 109,408 shares of company stock valued at $31,607,768 in the last three months. 0.33% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

UNH has been the subject of a number of recent research reports. Truist Financial reiterated a “buy” rating and set a $360.00 price objective (down previously from $580.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. Barclays reduced their price target on shares of UnitedHealth Group to $350.00 and set an “overweight” rating for the company in a research report on Monday. Raymond James cut UnitedHealth Group from a “strong-buy” rating to a “market perform” rating in a research report on Wednesday, May 14th. Hsbc Global Res lowered shares of UnitedHealth Group from a “hold” rating to a “moderate sell” rating in a report on Wednesday, May 21st. Finally, Bank of America lowered UnitedHealth Group from a “buy” rating to a “neutral” rating and dropped their target price for the company from $560.00 to $350.00 in a research report on Wednesday, May 14th. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating and seventeen have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $428.43.

UnitedHealth Group Stock Performance

Shares of UnitedHealth Group stock opened at $295.61 on Friday. The firm has a market capitalization of $268.16 billion, a P/E ratio of 19.07, a PEG ratio of 1.37 and a beta of 0.56. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The company has a 50 day moving average price of $413.43 and a 200 day moving average price of $486.09. UnitedHealth Group Incorporated has a 52 week low of $248.88 and a 52 week high of $630.73.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.29 by ($0.09). The business had revenue of $109.58 billion for the quarter, compared to analysts’ expectations of $111.56 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. During the same period last year, the business earned $6.91 EPS. Sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th will be given a $2.21 dividend. The ex-dividend date is Monday, June 16th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.99%. This is an increase from UnitedHealth Group’s previous quarterly dividend of $2.10. UnitedHealth Group’s dividend payout ratio is 35.18%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.